secwatch.observer — SEC 8-K summary
======================================

Issuer:     Forte Biosciences, Inc. (FBRX)
CIK:        0001419041
Form:       8-K
Filed at:   2022-08-12T23:59:59+00:00
Accession:  0001193125-22-220060
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Forte Biosciences files prospectus supplement for additional $2.7M ATM offering
-------------------------------------------------------------------------------

- Filed new prospectus supplement for sale of up to $2.7M of common stock via existing ATM agreement with Ladenburg Thalmann.
- Aggregate offering under the ATM agreement remains capped at $25M; previously $7M was registered.
- Proceeds to be used for general corporate purposes, including funding existing and potential new clinical programs.
- Shares issued under previously effective S-3 registration statement filed May 28, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419041/000119312522220060/0001193125-22-220060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419041/000119312522220060/d365470d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-220060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer